Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”

Response to: “A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial”

Bibliographic Details
Main Authors: Annelise Madison, Barbara L. Andersen, Ali Ajam
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Arthritis Research & Therapy
Online Access:http://link.springer.com/article/10.1186/s13075-019-1848-4

Internet

http://link.springer.com/article/10.1186/s13075-019-1848-4

Similar Items